Olin and Huntsman completed an all‑stock merger that will create a North American chemicals powerhouse. The deal swaps 0.5476 Olin shares for each Huntsman share, giving Olin shareholders 54.5% of the new entity and Huntsman investors 45.5%. The combined company will have last year’s revenue of roughly $12.5 billion, positioning it among the largest in the sector.

Based on Olin’s closing price of $25.30, the transaction values Huntsman at about $13.85 per share—roughly 13% below Monday’s close of $15.89. The valuation reflects a modest discount to the market, a common tactic to entice shareholders while keeping the deal attractive under regulatory scrutiny.

The merger consolidates overlapping product lines and streamlines supply chains, potentially yielding cost synergies estimated at $200 million annually. Investors will watch how the combined entity balances its portfolio of specialty and commodity chemicals to sustain growth. Analysts expect the combined company to leverage its expanded R&D footprint to drive innovation in high‑margin segments.

Regulatory approval will hinge on antitrust reviews, but the transaction aligns with industry trends toward consolidation amid volatile raw‑material costs. Once closed, the new company will rank among the top three U.S. chemical producers by revenue, giving it greater bargaining power with suppliers and customers.